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Summary: The purpose of this study was to clarify the effect of aging on brain γ-aminobutyric acid metabolism.
We measured the cerebrospinal fluid γ-aminobutyric acid concentration in subjects of various ages, including
healthy volunteers and patients without neurological or psychiatric disease. The cerebrospinal fluid γ-
aminobutyric acid concentration was determined by radiolabelled receptor assay using [3Hty-aminobutyric
acid. Cerebrospinal fluid γ-aminobutyric acid was significantly higher in the control group (20s and 30s) than
in the groups of subjects in their 50s, 60s, 70s and 80s. There was a significant negative correlation between
cerebrospinal γ-aminobutyric acid concentration and age (p < 0.01). These data suggest that dysfunction of
brain γ-aminobutyric acid metabolism increases with age, and that the various symptoms caused by abnormal
γ-aminobutyric acid metabolism in the brain are therefore more likely to appear in elderly people.
T ^ , ^ (4, 5). Other studies have also shown low cerebrospi-Introduction , « . « t j r r
nal fluid γ-aminobutyric acid concentrations in Hun-
γ-Aminobutyric acid is thought to be a major inhib- tington's disease (6) and Alzheimer's disease (7). Cere-
itory neurotransmitter. Biochemical studies have re- brospinal fluid is believed to be formed in the choroid
vealed that the content of γ-aminobutyric acid is much plexus and is in contact with both the brain and the
lower than normal in the striatum and substantia spinal cord. Total cerebrospinal fluid γ-aminobutyric
nigra of autopsied brains from patients with Hunting- acid concentrations are related primarily to brain γ-
ton's disease (1), and the association between neuro- aminobutyric acid concentrations and are minimally
psychiatric diseases and the brain γ-aminobutyric acid affected by changes in the peripheral γ-aminobutyric
system has been studied (2, 3). Radiolabelled receptor acid concentration (8). Changes in cerebrospinal fluid
assays can be used to observe changes in neurotrans- γ-aminobutyric acid concentrations may therefore re-
mission. Recently, γ-aminobutyric acid was reliably fleet changes in brain γ-aminobutyric acid metabo-
measured in cerebrospinal fluid by a γ-aminobutyric lism.
acid radiolabelled receptor assay, and it was shown As the proportion of aged people in the Japanese
that this value can be used as an index of the function population increases, their medical problems are re-
of the brain γ-aminobutyric acid system. We used the ceiving more attention. Among these are neurological
γ-aminobutyric acid radiolabelled receptor assay and disorders, including choreatic movement and demen-
found abnormally low concentrations of cerebrospi- tia. In the present study, we measured cerebrospinal
nal fluid γ-aminobutyric acid in patients with neuro- fluid γ-aminobutyric acid concentrations, using a ra-
psychiatric diseases, including presenile dementia, diolabelled receptor assay, to determine whether γ-
Parkinsorfs disease, Huntingtorfs disease, olivoponto- aminobutyric acid metabolism changes during normal
cerebellar atrophy and late cortical cerebellar atrophy aging.
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Subjects and Methods
Subjects
The subjects consisted of 55 healthy volunteers and patients
without neurological or psychiatric disease (30 men and 25
women) who were not receiving drugs that act on the central
nervous system. Their ages ranged from 21 to 82 years (mean
± SD, 48.4 ± 18.9). The age distribution is shown in table 1.
Those in their 20s and 30s were used as controls, and were
compared with the other subjects.
Procedures
All subjects were maintained on absolute bed rest, and oral
intake was forbidden for the 15 hours before the cerebrospinal
fluid sample was taken. Some of the patients were not taking
medication. In the others, drug therapy was stopped for at least
14 days before the sample was taken. Lumbar puncture was
performed at 9 am, in the standard fashion with the patients in
the lateral decubitus position. Ten millilitres of cerebrospinal
fluid were withdrawn and the final 5 ml was immediately frozen
by immersion in a mixture of acetone and solid carbon dioxide,
and kept at -70 °C until assayed.
Receptor preparat ion
For the receptor preparation, crude synaptic membrane was
prepared from whole rat brains by a modification of the method
of De Robertis et al. (9). Briefly, Sprague-Dawley rats (body
weight 200 — 250 g) were decapitated and the whole brains were
immediately removed. The tissue was homogenized in 10 vol-
umes of an ice-cold 0.32 mol/1 sucrose solution in a Brinkman
Polytron PT-10 homogenizer for 20 s. The homogenate was
centrifuged at 900 g for 10 min, and the supernatant was further
centrifuged at 11 500 g for 20 min. The pellet (P2 fraction) was
resuspended in 10 volumes of Tris-HCl buffer (50 mmol/1, pH
7.6) and kept at — 70 °C until assayed. Before analysis, the
receptor preparation was thawed and homogenized with a glass
homogenizer in 100 volumes of Tris-HCl buffer, then centri-
fuged at 50 000 g for 20 min. The supernatant was discarded
and the pellet was resuspended in 100 volumes of Tris-HCl
buffer containing 0.5 ml/1 Triton X-100. The suspension was
shaken in a water bath at 37 °C for 30 min, then centrifuged
twice at 50 000 g for 20 min. The pellet was resuspended in 20
volumes of Tris-HCl buffer. This gave a tissue protein concen-
tration of about 0.6 g/1.
Determination of γ-aminobutyric acid in cerebro-
spinal fluid
The cerebrospinal fluid γ-aminobutyric acid concentration was
measured by the radiolabelled receptor assay method of Enna
& Snyder (10) as modified by Kuroda et al. (4), with crude
synaptic membranes prepared from the rat brain. In brief, 0.5
ml of the receptor preparation was placed in a glass tube
containing 0.2 ml of various concentrations (100 pmol/1 — 10
μιηοΐ/ΐ, final concentration) of γ-aminobutyric acid (for stand-
ard curve) or cerebrospinal fluid, 0.2 ml of Tris-HCl buffer and
0.1 ml of [3Hty-aminobutyric acid (final concentration 6.4
nmol/1, specific activity 2109 TBq/mol (57 Ci/mmol), Amer-
sham). The samples were incubated in ice for 30 min and the
reaction was stopped by filtration through glass fibre filters
(Whatman GF/C) under reduced pressure. Finally, each filter
was washed twice with 5 ml of cold Tris-HCl buffer, then placed
in a scintillation vial with 10ml of scintillation fluor. The
radioactivity of the filter was counted with an automatic beta
counter. Specific binding was obtained by subtracting from the
total bound radioactivity the amount not displaced by 1 mmol/1
γ-aminobutyric acid (blank). All samples were analysed in tri-
plicate. Cerebrospinal fluid γ-aminobutyric acid concentrations
were calculated with the aid of the standard γ-aminobutyric
acid radiolabelled receptor assay curve.
Post hoc Dunnett's multiple comparison test (11) was performed
following one-way analysis of variance to compare the cerebro-
spinal fluid γ-aminobutyric acid concentrations in controls with
those in the other age groups.
All data are expressed as means + SEMs.
Results
Table 1 shows the cerebrospinal fluid γ-aminobutyric
acid concentrations in each age group. The concen-
trations were significantly lower in subjects who were
at least 50 years old than in those who were less than
40 years old.
Tab. 1. Cerebrospinal fluid γ-aminobutyric acid concentrations
in various age groups
Age (a) N Cerebrospinal fluid γ-aminobutyric
acid (nmol/1)
21-39
(control)
40-49
50-59
60-69
70-79
80-82
20
9
9
7
7
3
127.5 ± 9.2
99.9 ± 15.9
92.4 ± 5.5*
74.1 ± 9.2**
66.0 ± 8.4**
39.1 ± 7.2**
The data are shown as means ± SEMs.
* p < 0.01, ** p < 0.001 compared with the control group
(21 — 39 a) by post hoc Dunnetfs multiple comparison test fol-
lowing one-way analysis of variance.
Figure 1 shows that there was a significant negative
correlation between cerebrospinal fluid γ-aminobu-
tyric acid concentration and age (p < 0.01). This was
true for the group as a whole, and also when the data
from the men and the women were analysed sepa-
rately (p < 0.01). The age-related decrease was
slightly greater, and the correlation was slightly
stronger in women.
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Relationship between cerebrospinal fluid γ-aminobu-
tyric acid concentration and age.
Total (N = 55): y = -1.41x + 145,
• males (N = 30): y = -1.19x + 133,
α females (N = 25): y = -1.74x + 176.
Linear regression analysis showed a significant negative
correlation (r = —0.81) (p < 0.01). Significant negative
correlations (p < 0.01) were also found in men only
(r = —0.79) and in women only (r = -0.88).
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Discussion
γ-Aminobutyric acid was first detected in neural tissue
in 1950 (12, 13). In 1954, Hayashi (14) reported in-
hibition of seizures after γ-aminobutyric acid was
injected into the cerebral cortex of mammals. This
suggested that γ-aminobutyric acid is an inhibitory
neurotransmitter, and subsequent studies have con-
firmed this. Radiolabelled receptor assays (15) can be
used to observe changes in neuro-transmission, and
this type of assay has also contributed to studies of
γ-aminobutyric acid receptors. Kuroda (16) has al-
ready reported that the dilution curve of cerebrospinal
fluid is parallel to the standard γ-aminobutyric acid
radiolabelled receptor assay curve, and that the cross-
reactivity of glycine, L-glutamic acid, and taurine is
less than 0.02%. The cerebrospinal fluid γ-aminobu-
tyric acid concentration could be measured accurately
down to 5 nmol/1 by the radiolabelled receptor assay.
The existence of rostrocaudal γ-aminobutyric acid
concentration gradients (16) suggests that the cere-
brospinal fluid γ-aminobutyric acid may reflect brain
γ-aminobutyric acid system activity. Although the γ-
aminobutyric acid concentration is about 50% lower
in the cerebrospinal fluid than in plasma, γ-acetylenic
γ-aminobutyric acid, which is known to increase brain
γ-aminobutyric acid, increased both plasma and cere-
brospinal γ-aminobutyric acid in a dose dependent
manner (17). These data indicate that the cerebrospi-
nal fluid γ-aminobutyric acid originates from the
brain and is minimally affected by changes in the
peripheral γ-aminobutyric acid concentration.
We previously reported the cerebrospinal fluid γ-ami-
nobutyric acid concentrations in patients with various
neurological and psychiatric diseases, as measured by
radiolabelled receptor assay (4, 5). In this study, to
evaluate changes in brain γ-aminobutyric acid metab-
olism with age, the cerebrospinal fluid γ-aminobutyric
acid concentrations were compared among subjects
of various ages, consisting of both normal volunteers
and patients without neurological or psychiatric dis-
ease. The cerebrospinal fluid γ-aminobutyric acid con-
centrations were significantly lower in the subjects
who were at least 50 years old than in those who were
less than 40 years old (tab. 1). In addition, the cere-
brospinal fluid γ-aminobutyric acid concentration was
negatively correlated with age, in both men and
women (fig. 1). In particular, the cerebrospinal fluid
γ-aminobutyric acid concentrations of subjects in
their 70s and 80s were about 50% and 30%, respec-
tively, of the concentration in the control group.
Hare et al. (18) reported an age-related significant
decrease in cerebrospinal fluid γ-aminobutyric acid
concentration among women, but only a slight de-
crease among men. In this study, computed tomog-
raphy scans showed relatively slight atrophic changes
in the brain (data not shown). Therefore, the decrease
in cerebrospinal fluid γ-aminobutyric acid concentra-
tion was probably associated with abnormal γ-ami-
nobutyric acid metabolism, rather than with a de-
crease in γ-aminobutyric acid content due to age-
related atrophy of the cerebral cortex and cerebellum,
which contain large amounts of γ-aminobutyric acid.
McGeer (19) reported an age-related decrease in the
activity of glutamic acid decarboxylase, which is a γ-
aminobutyric acid synthetase. This might decrease the
brain γ-aminobutyric acid concentration and thus de-
crease the cerebrospinal fluid γ-aminobutyric acid
concentration. Involuntary movements are frequently
seen in the elderly, and memory is gradually impaired.
A decrease in the cerebrospinal fluid γ-aminobutyric
acid concentration has been reported in Alzheimer's
disease, which is characterized by dementia, in Hun-
tington's disease, which is characterized by involun-
tary movements, and in Parkinson's disease (6 — 8,
20). In particular, diseases characterized by involun-
tary movements have been said to be closely associ-
ated with γ-aminobutyric acid metabolism (6, 21).
Although the brain γ-aminobutyric acid system is not
the only system involved in the aging process, the
present study showed that the cerebrospinal fluid γ-
aminobutyric acid concentration markedly decreased
with age. This suggests that brain γ-aminobutyric acid
metabolism is closely associated with various symp-
toms in the aged, and that the measurement of cere-
brospinal fluid γ-aminobutyric acid can be used to
evaluate this association.
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